{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:01:30Z","timestamp":1793131290395,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22507110"],"award-info":[{"award-number":["22507110"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","award":["14103121"],"award-info":[{"award-number":["14103121"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","award":["12102120"],"award-info":[{"award-number":["12102120"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","award":["14109721"],"award-info":[{"award-number":["14109721"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","award":["14103420"],"award-info":[{"award-number":["14103420"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","award":["T12-201\/20-R"],"award-info":[{"award-number":["T12-201\/20-R"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001747","name":"Hong Kong Baptist University","doi-asserted-by":"publisher","award":["RC-ICRS\/19\\u201320\/01"],"award-info":[{"award-number":["RC-ICRS\/19\\u201320\/01"]}],"id":[{"id":"10.13039\/501100001747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007162","name":"Guangdong Provincial Department of Science and Technology","doi-asserted-by":"publisher","award":["2022A1515110044"],"award-info":[{"award-number":["2022A1515110044"]}],"id":[{"id":"10.13039\/501100007162","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007162","name":"Guangdong Provincial Department of Science and Technology","doi-asserted-by":"publisher","award":["2019B1515120089"],"award-info":[{"award-number":["2019B1515120089"]}],"id":[{"id":"10.13039\/501100007162","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003452","name":"Innovation and Technology Commission","doi-asserted-by":"publisher","award":["ITS\/523\/24FP"],"award-info":[{"award-number":["ITS\/523\/24FP"]}],"id":[{"id":"10.13039\/501100003452","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017649","name":"Government of the Hong Kong Special Administrative Region of the People","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017649","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFA0800804"],"award-info":[{"award-number":["2018YFA0800804"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004853","name":"Chinese University of Hong Kong","doi-asserted-by":"publisher","award":["4054660"],"award-info":[{"award-number":["4054660"]}],"id":[{"id":"10.13039\/501100004853","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010909","name":"Excellent Young Scientists Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010909","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.xcrm.2026.102763","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T14:42:50Z","timestamp":1776955370000},"page":"102763","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Intracellular sclerostin promotes tumor progression and metastasis as a potential therapeutic target in triple-negative breast cancer"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2197-0439","authenticated-orcid":false,"given":"Meiheng","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangying","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zefeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hewen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijian","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhui","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daqing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Lai","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.102763_bib1","first-page":"S1470","article-title":"Projected global rise in breast cancer incidence and mortality by 2050","volume":"6","author":"Devi","year":"2025","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.xcrm.2026.102763_bib2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","article-title":"Treatment landscape of triple-negative breast cancer - expanded options, evolving needs","volume":"19","author":"Bianchini","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2026.102763_bib3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa2202809","article-title":"Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer","volume":"387","author":"Cortes","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102763_bib4","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1200\/JCO.23.01409","article-title":"Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression","volume":"42","author":"Bardia","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2026.102763_bib5","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1200\/JCO.2016.70.8297","article-title":"Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer","volume":"35","author":"Bardia","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2026.102763_bib6","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1038\/s41467-022-31997-8","article-title":"Targeting loop3 of sclerostin preserves its cardiovascular protective action and promotes bone formation","volume":"13","author":"Yu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102763_bib7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12943-020-01276-5","article-title":"Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities","volume":"19","author":"Xu","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.xcrm.2026.102763_bib8","article-title":"Sclerostin inhibition alleviates breast cancer-induced bone metastases and muscle weakness","volume":"5","author":"Hesse","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.xcrm.2026.102763_bib9","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12943-022-01697-4","article-title":"Targeting SOST using a small-molecule compound retards breast cancer bone metastasis","volume":"21","author":"Sun","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.xcrm.2026.102763_bib10","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1111\/cas.15765","article-title":"Sclerostin blockade promotes bone metastases of Wnt-responsive breast cancer cells","volume":"114","author":"Hiraga","year":"2023","journal-title":"Cancer Sci."},{"key":"10.1016\/j.xcrm.2026.102763_bib11","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1038\/s41590-019-0542-7","article-title":"Inducible degradation of lncRNA Sros1 promotes IFN-\u03b3-mediated activation of innate immune responses by stabilizing Stat1 mRNA","volume":"20","author":"Xu","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2026.102763_bib12","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.biopha.2013.06.006","article-title":"Caprin-1 is a novel microRNA-223 target for regulating the proliferation and invasion of human breast cancer cells","volume":"67","author":"Gong","year":"2013","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.xcrm.2026.102763_bib13","first-page":"15","article-title":"Role of caprin-1 in carcinogenesis","volume":"18","author":"Yang","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.xcrm.2026.102763_bib14","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/s41388-023-02610-z","article-title":"circIPO7 dissociates caprin-1 from ribosomes and inhibits gastric cancer cell proliferation by suppressing EGFR and mTOR","volume":"42","author":"Liu","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.xcrm.2026.102763_bib15","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1007\/s00198-014-2737-y","article-title":"Adult Brtl\/+ mouse model of osteogenesis imperfecta demonstrates anabolic response to sclerostin antibody treatment with increased bone mass and strength","volume":"25","author":"Sinder","year":"2014","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.xcrm.2026.102763_bib16","doi-asserted-by":"crossref","DOI":"10.34133\/research.0762","article-title":"CCN5 Drives Leydig Cell Aging and Testicular Dysfunction: Insights into Fibrosis, Lipid Dysregulation, and Therapeutic Potential","volume":"8","author":"Tan","year":"2025","journal-title":"Research"},{"key":"10.1016\/j.xcrm.2026.102763_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2023.102073","article-title":"A bimolecular modification strategy for developing long-lasting bone anabolic aptamer","volume":"34","author":"Zhang","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.xcrm.2026.102763_bib18","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/s41467-026-68526-w","article-title":"Adipocytic sclerostin loop3-LRP4 interaction required by sclerostin to impair whole-body lipid and glucose metabolism","volume":"17","author":"Jiang","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102763_bib19","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1038\/s41596-024-01011-0","article-title":"The HADDOCK2.4 web server for integrative modeling of biomolecular complexes","volume":"19","author":"Honorato","year":"2024","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.xcrm.2026.102763_bib20","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1021\/acs.jmedchem.3c00075","article-title":"Discovery of a Potent, Cooperative, and Selective SOS1 PROTAC ZZ151 with In Vivo Antitumor Efficacy in KRAS-Mutant Cancers","volume":"66","author":"Zhou","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.xcrm.2026.102763_bib21","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/anie.200805427","article-title":"Evidence for a stereoelectronic effect in human oxygen sensing","volume":"48","author":"Loenarz","year":"2009","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.xcrm.2026.102763_bib22","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41698-023-00407-7","article-title":"Targeting CDK1 in cancer: mechanisms and implications","volume":"7","author":"Wang","year":"2023","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.xcrm.2026.102763_bib23","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10549-022-06801-2","article-title":"The clinical significance of cyclin B1 (CCNB1) in invasive breast cancer with emphasis on its contribution to lymphovascular invasion development","volume":"198","author":"Aljohani","year":"2023","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.xcrm.2026.102763_bib24","doi-asserted-by":"crossref","first-page":"5645","DOI":"10.7150\/thno.63177","article-title":"Therapeutic aptamer targeting sclerostin loop3 for promoting bone formation without increasing cardiovascular risk in osteogenesis imperfecta mice","volume":"12","author":"Wang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.xcrm.2026.102763_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe5357","article-title":"S100A8\/S100A9 cytokine acts as a transcriptional coactivator during breast cellular transformation","volume":"7","author":"Song","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.xcrm.2026.102763_bib26","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.molcel.2019.04.005","article-title":"PD-L1 (B7-H1) Competes with the RNA Exosome to Regulate the DNA Damage Response and Can Be Targeted to Sensitize to Radiation or Chemotherapy","volume":"74","author":"Tu","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.xcrm.2026.102763_bib27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41419-020-03304-0","article-title":"STIM1 promotes angiogenesis by reducing exosomal miR-145 in breast cancer MDA-MB-231 cells","volume":"12","author":"Pan","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.xcrm.2026.102763_bib28","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1158\/0008-5472.CAN-19-1145","article-title":"Integrin \u03b24-Targeted Cancer Immunotherapies Inhibit Tumor Growth and Decrease Metastasis","volume":"80","author":"Ruan","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102763_bib29","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1158\/0008-5472.CAN-23-2491","article-title":"ACSL4-Mediated Membrane Phospholipid Remodeling Induces Integrin \u03b21 Activation to Facilitate Triple-Negative Breast Cancer Metastasis","volume":"84","author":"Qiu","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102763_bib30","article-title":"Biomimetic Liposomal Nanoplatinum for Targeted Cancer Chemophototherapy","volume":"8","author":"Liu","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.xcrm.2026.102763_bib31","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nature15756","article-title":"Tumour exosome integrins determine organotropic metastasis","volume":"527","author":"Hoshino","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102763_bib32","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/bjc.2015.267","article-title":"MDA-MB-231 breast cancer cells overexpressing single VEGF isoforms display distinct colonisation characteristics","volume":"113","author":"Di Benedetto","year":"2015","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.xcrm.2026.102763_bib33","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s43018-022-00337-6","article-title":"A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology","volume":"3","author":"Guillen","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.xcrm.2026.102763_bib34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4132\/jptm.2020.09.29","article-title":"Automated immunohistochemical assessment ability to evaluate estrogen and progesterone receptor status compared with quantitative reverse transcription-polymerase chain reaction in breast carcinoma patients","volume":"55","author":"Jeon","year":"2021","journal-title":"J. Pathol. Transl. Med."},{"key":"10.1016\/j.xcrm.2026.102763_bib35","doi-asserted-by":"crossref","first-page":"8216","DOI":"10.1039\/D2CS00387B","article-title":"Discovery of small molecule ligands for the von Hippel-Lindau (VHL) E3 ligase and their use as inhibitors and PROTAC degraders","volume":"51","author":"Diehl","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.xcrm.2026.102763_bib36","doi-asserted-by":"crossref","first-page":"35021","DOI":"10.1021\/acsami.6b12877","article-title":"Multifunctional Polymer Ligand Interface CdZnSeS\/ZnS Quantum Dot\/Cy3-Labeled Protein Pairs as Sensitive FRET Sensors","volume":"8","author":"Yang","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.xcrm.2026.102763_bib37","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s41419-022-04639-6","article-title":"Juxtamembrane 2 mimic peptide competitively inhibits mitochondrial trafficking and activates ROS-mediated apoptosis pathway to exert anti-tumor effects","volume":"13","author":"He","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.xcrm.2026.102763_bib38","article-title":"Cholinergic signaling via muscarinic M1 receptor confers resistance to docetaxel in prostate cancer","volume":"5","author":"Wang","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2026.102763_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12868","article-title":"Local microRNA delivery targets Palladin and prevents metastatic breast cancer","volume":"7","author":"Gilam","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102763_bib40","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/s41467-017-01565-6","article-title":"A water-soluble nucleolin aptamer-paclitaxel conjugate for tumor-specific targeting in ovarian cancer","volume":"8","author":"Li","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102763_bib41","doi-asserted-by":"crossref","first-page":"5095","DOI":"10.1172\/JCI99673","article-title":"\u0394Np63-driven recruitment of myeloid-derived suppressor cells promotes metastasis in triple-negative breast cancer","volume":"128","author":"Kumar","year":"2018","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.102763_bib42","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41556-018-0256-3","article-title":"Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models","volume":"21","author":"Keklikoglou","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.xcrm.2026.102763_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202205873","article-title":"Phosphorylation of USP29 by CDK1 Governs TWIST1 Stability and Oncogenic Functions","volume":"10","author":"Guan","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.xcrm.2026.102763_bib44","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1158\/0008-5472.CAN-18-3369","article-title":"A Direct Podocalyxin-Dynamin-2 Interaction Regulates Cytoskeletal Dynamics to Promote Migration and Metastasis in Pancreatic Cancer Cells","volume":"79","author":"Wong","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102763_bib45","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/s41420-023-01543-6","article-title":"FGF19 induces the cell cycle arrest at G2-phase in chondrocytes","volume":"9","author":"Chen","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.xcrm.2026.102763_bib46","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102763_bib47","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pro.3943","article-title":"UCSF ChimeraX: Structure visualization for researchers, educators, and developers","volume":"30","author":"Pettersen","year":"2021","journal-title":"Protein Sci."},{"key":"10.1016\/j.xcrm.2026.102763_bib48","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aay2801","article-title":"A chemically unmodified agonistic DNA with growth factor functionality for in vivo therapeutic application","volume":"6","author":"Ueki","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.xcrm.2026.102763_bib49","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1038\/s41467-018-05974-z","article-title":"Inhibition of osteoblastic Smurf1 promotes bone formation in mouse models of distinctive age-related osteoporosis","volume":"9","author":"Liang","year":"2018","journal-title":"Nat. Commun."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126001801?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126001801?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T03:41:01Z","timestamp":1783136461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126001801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2666379126001801"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102763","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intracellular sclerostin promotes tumor progression and metastasis as a potential therapeutic target in triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102763","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102763"}}